Deutsche Bank’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-123,197
Closed -$70.2K 3733
2025
Q1
$70.2K Sell
123,197
-6,122
-5% -$6.04K ﹤0.01% 3304
2024
Q4
$185K Buy
129,319
+97,318
+304% +$218K ﹤0.01% 3115
2024
Q3
$61.8K Buy
32,001
+8,787
+38% +$24.8K ﹤0.01% 3320
2024
Q2
$72K Sell
23,214
-3,398
-13% -$14K ﹤0.01% 3235
2024
Q1
$139K Buy
26,612
+20,490
+335% +$98K ﹤0.01% 3018
2023
Q4
$19.8K Sell
6,122
-23,202
-79% -$50.1K ﹤0.01% 3494
2023
Q3
$74.8K Sell
29,324
-7,037
-19% -$29.5K ﹤0.01% 3291
2023
Q2
$213K Buy
36,361
+222
+0.6% +$1.29K ﹤0.01% 2842
2023
Q1
$103K Buy
36,139
+23,710
+191% +$66.6K ﹤0.01% 3310
2022
Q4
$25K Buy
12,429
+188
+2% +$459 ﹤0.01% 3738
2022
Q3
$35K Sell
12,241
-1,868
-13% -$8.72K ﹤0.01% 3680
2022
Q2
$79K Sell
14,109
-2,772
-16% -$22.4K ﹤0.01% 3620
2022
Q1
$199K Buy
16,881
+8,415
+99% +$102K ﹤0.01% 3270
2021
Q4
$160K Buy
8,466
+450
+6% +$9.81K ﹤0.01% 3486
2021
Q3
$166K Buy
+8,016
New +$172K ﹤0.01% 3667

Other funds holding TNYA

Deutsche Bank's TNYA Position: Q2 2025 in Review

Deutsche Bank sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 123,197 shares — an estimated $70.2K sold.

Deutsche Bank first reported a position in TNYA in Q3 2021 and held it in 15 quarters. The position peaked at $213K in Q2 2023. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Deutsche Bank reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 123,197 Tenaya Therapeutics shares in Q2 2025, an estimated $70.2K.
  • Deutsche Bank first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 15 quarters.
  • Deutsche Bank's Tenaya Therapeutics position peaked at $213K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.